Emtricitabine (FTC)
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), Gilead Sciences, French National Agency for Research on AIDS and Viral Hepatitis, Janssen Scientific Affairs, LLC, National University Hospital, Singapore
Conditions
Alzheimer Dementia (AD)HIV InfectionHIV InfectionsHealthyMild Cognitive Impairment (MCI)Pregnancy
Phase 1
Safety and Effectiveness of Emtricitabine, Efavirenz, and Didanosine in HIV Infected Children Who Have Taken Few or No Anti-HIV Drugs
CompletedNCT00016718
Start: 2001-08-31End: 2009-01-31Updated: 2021-11-05
Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status
CompletedNCT01040091
Start: 2009-12-31End: 2014-04-30Updated: 2016-12-16
Study to Evaluate the Relative Bioavailability of Fixed-dose Combination Tablet Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) as a Whole Tablet, as a Split Tablet, and as Crushed Tablet in Healthy Adult Participants
CompletedNCT02984852
Start: 2016-12-31End: 2017-02-28Updated: 2025-02-03
Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study
RecruitingNCT07210528
Start: 2025-06-30End: 2026-04-30Target: 48Updated: 2025-10-07
Phase 2
Phase 3
Tenofovir Disoproxil Fumarate/Emtricitabine/Efavirenz Versus Combivir/Efavirenz in Antiretroviral-Naive HIV-1 Infected Subjects
CompletedNCT00112047
Start: 2003-07-31End: 2009-06-30Updated: 2010-10-13
Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)
CompletedNCT00158457
Start: 2004-06-30End: 2006-12-31Updated: 2007-07-03